Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
D-mannose is a naturally occurring monosaccharide (simple sugar) closely related to glucose and found in many fruits, as well as produced endogenously in the human body. It plays a key role in glycosylation of proteins and is involved in various biological processes. D-mannose is primarily used as a dietary supplement for the prevention and treatment of urinary tract infections (UTIs), although robust clinical evidence for this use remains limited. Its main mechanism involves binding to FimH adhesin on type 1 fimbriae of uropathogenic Escherichia coli (UPEC), thereby preventing bacterial adherence to urothelial cells and reducing infection risk. Additionally, it is approved for treating carbohydrate-deficient glycoprotein syndrome type 1b, an inherited metabolic disorder, where it helps correct glycosylation defects[1][3][4][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on d-mannose.